Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.
Chronic activation of innate immunity takes place in obesity and initiated by the hypertrophic adipocytes which obtain a pro-inflammatory phenotype. The corticotrophin-releasing factor (CRF) family of neuropeptides and their receptors (CRF1 and CRF2) affect stress response and innate immunity. Adipo...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8851cf02b9ff49209131b5071f5507d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8851cf02b9ff49209131b5071f5507d0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8851cf02b9ff49209131b5071f5507d02021-11-18T08:18:59ZCorticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.1932-620310.1371/journal.pone.0097060https://doaj.org/article/8851cf02b9ff49209131b5071f5507d02014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24835211/?tool=EBIhttps://doaj.org/toc/1932-6203Chronic activation of innate immunity takes place in obesity and initiated by the hypertrophic adipocytes which obtain a pro-inflammatory phenotype. The corticotrophin-releasing factor (CRF) family of neuropeptides and their receptors (CRF1 and CRF2) affect stress response and innate immunity. Adipose tissue expresses a complete CRF system. The aim of this study was to examine the role of CRF neuropeptides in the immune phenotype of adipocytes assessed by their expression of the toll-like receptor-4 (TLR4), the production of inflammatory cytokines IL-6, TNF-α and IL-1β, chemokines IL-8, monocyte attractant protein-1 (MCP-1) and of the adipokines adiponectin, resistin and leptin. Our data are as follows: (a) CRF, UCN2 and UCN3 are expressed in human white adipocytes as well as CRFR1a, CRFR2a and CRFR2b but not CRFR2c. 3T3L1 pre-adipocytes and differentiated adipocytes expressed both CRF1 and CRF2 receptors and UCN3, while UCN2 was detected only in differentiated adipocytes. CRF2 was up-regulated in mouse mature adipocytes. (b) CRF1 agonists suppressed media- and LPS-induced pre-adipocyte differentiation while CRF2 receptor agonists had no effect. (c) In mouse pre-adipocytes, CRF2 agonists suppressed TLR4 expression and the production of IL-6, CXCL1 and adiponectin while CRF1 agonists had no effect. (d) In mature mouse adipocytes LPS induced IL-6 and CXCL1 production and suppressed leptin. (e) In human visceral adipocytes LPS induced IL-6, TNF-α, IL-8, MCP-1 and leptin production and suppressed adiponectin and resistin. (f) In mouse mature adipocytes CRF1 and CRF2 agonists suppressed basal and LPS-induced production of inflammatory cytokines, TLR4 expression and adiponectin production, while in human visceral adipocytes CRF and UCN1 suppressed basal and LPS-induced IL-6, TNF-α, IL-8 and MCP-1 production. In conclusion, the effects of the activation of CRF1 and CRF2 may be significant in ameliorating the pro-inflammatory activity of adipocytes in obesity.Eirini DermitzakiGeorge LiapakisAriadne AndroulidakiMaria VenihakiJohn MelissasChristos TsatsanisAndrew N MargiorisPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 5, p e97060 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Eirini Dermitzaki George Liapakis Ariadne Androulidaki Maria Venihaki John Melissas Christos Tsatsanis Andrew N Margioris Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. |
description |
Chronic activation of innate immunity takes place in obesity and initiated by the hypertrophic adipocytes which obtain a pro-inflammatory phenotype. The corticotrophin-releasing factor (CRF) family of neuropeptides and their receptors (CRF1 and CRF2) affect stress response and innate immunity. Adipose tissue expresses a complete CRF system. The aim of this study was to examine the role of CRF neuropeptides in the immune phenotype of adipocytes assessed by their expression of the toll-like receptor-4 (TLR4), the production of inflammatory cytokines IL-6, TNF-α and IL-1β, chemokines IL-8, monocyte attractant protein-1 (MCP-1) and of the adipokines adiponectin, resistin and leptin. Our data are as follows: (a) CRF, UCN2 and UCN3 are expressed in human white adipocytes as well as CRFR1a, CRFR2a and CRFR2b but not CRFR2c. 3T3L1 pre-adipocytes and differentiated adipocytes expressed both CRF1 and CRF2 receptors and UCN3, while UCN2 was detected only in differentiated adipocytes. CRF2 was up-regulated in mouse mature adipocytes. (b) CRF1 agonists suppressed media- and LPS-induced pre-adipocyte differentiation while CRF2 receptor agonists had no effect. (c) In mouse pre-adipocytes, CRF2 agonists suppressed TLR4 expression and the production of IL-6, CXCL1 and adiponectin while CRF1 agonists had no effect. (d) In mature mouse adipocytes LPS induced IL-6 and CXCL1 production and suppressed leptin. (e) In human visceral adipocytes LPS induced IL-6, TNF-α, IL-8, MCP-1 and leptin production and suppressed adiponectin and resistin. (f) In mouse mature adipocytes CRF1 and CRF2 agonists suppressed basal and LPS-induced production of inflammatory cytokines, TLR4 expression and adiponectin production, while in human visceral adipocytes CRF and UCN1 suppressed basal and LPS-induced IL-6, TNF-α, IL-8 and MCP-1 production. In conclusion, the effects of the activation of CRF1 and CRF2 may be significant in ameliorating the pro-inflammatory activity of adipocytes in obesity. |
format |
article |
author |
Eirini Dermitzaki George Liapakis Ariadne Androulidaki Maria Venihaki John Melissas Christos Tsatsanis Andrew N Margioris |
author_facet |
Eirini Dermitzaki George Liapakis Ariadne Androulidaki Maria Venihaki John Melissas Christos Tsatsanis Andrew N Margioris |
author_sort |
Eirini Dermitzaki |
title |
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. |
title_short |
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. |
title_full |
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. |
title_fullStr |
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. |
title_full_unstemmed |
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. |
title_sort |
corticotrophin-releasing factor (crf) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3t3l1 pre-adipocytes. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/8851cf02b9ff49209131b5071f5507d0 |
work_keys_str_mv |
AT eirinidermitzaki corticotrophinreleasingfactorcrfandtheurocortinsarepotentregulatorsoftheinflammatoryphenotypeofhumanandmousewhiteadipocytesandthedifferentiationofmouse3t3l1preadipocytes AT georgeliapakis corticotrophinreleasingfactorcrfandtheurocortinsarepotentregulatorsoftheinflammatoryphenotypeofhumanandmousewhiteadipocytesandthedifferentiationofmouse3t3l1preadipocytes AT ariadneandroulidaki corticotrophinreleasingfactorcrfandtheurocortinsarepotentregulatorsoftheinflammatoryphenotypeofhumanandmousewhiteadipocytesandthedifferentiationofmouse3t3l1preadipocytes AT mariavenihaki corticotrophinreleasingfactorcrfandtheurocortinsarepotentregulatorsoftheinflammatoryphenotypeofhumanandmousewhiteadipocytesandthedifferentiationofmouse3t3l1preadipocytes AT johnmelissas corticotrophinreleasingfactorcrfandtheurocortinsarepotentregulatorsoftheinflammatoryphenotypeofhumanandmousewhiteadipocytesandthedifferentiationofmouse3t3l1preadipocytes AT christostsatsanis corticotrophinreleasingfactorcrfandtheurocortinsarepotentregulatorsoftheinflammatoryphenotypeofhumanandmousewhiteadipocytesandthedifferentiationofmouse3t3l1preadipocytes AT andrewnmargioris corticotrophinreleasingfactorcrfandtheurocortinsarepotentregulatorsoftheinflammatoryphenotypeofhumanandmousewhiteadipocytesandthedifferentiationofmouse3t3l1preadipocytes |
_version_ |
1718421936361439232 |